Colorectal cancer molecular diagnostics market trends driving growth through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Colorectal Cancer Molecular Diagnostics Market Between 2026 And 2030?
The colorectal cancer molecular diagnostics market has experienced significant growth in recent years. Its value is expected to increase from $2.78 billion in 2025 to $3.02 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. This growth in the past can be attributed to several factors, including the rising incidence rates of colorectal cancer, the expansion of diagnostic laboratory infrastructure, a growing adoption of molecular testing protocols, improved awareness regarding early screening, and the increasing application of precision medicine approaches.
The colorectal cancer molecular diagnostics market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $4.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this growth during the forecast period include greater investments in precision oncology, an escalating demand for minimally invasive diagnostic methods, the broadening of genomic testing initiatives, the increasing incorporation of AI into cancer diagnostics, and an intensified emphasis on monitoring treatment responses. Key trends anticipated during the same period encompass the wider acceptance of molecular biomarker testing, an increased application of PCR and sequencing technologies, a surging need for personalized oncology diagnostics, the ongoing expansion of companion diagnostic development, and a heightened concentration on the early detection of cancer.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Colorectal Cancer Molecular Diagnostics Market Landscape?
The expanding incidence of colorectal cancer is anticipated to drive expansion in the colorectal cancer molecular diagnostics market in the future. Colorectal cancer is a condition impacting the colon or rectum, essential components of the digestive system. This cancer arises when cells within the colon or rectum proliferate uncontrollably, leading to tumor formation. The growing occurrence of colorectal cancer consequently elevates the need for molecular diagnostics in both detecting and managing the disease. As an illustration, in March 2023, the American Cancer Society, a US-based nationwide voluntary health organization committed to eradicating cancer, estimated that approximately 153,020 individuals would be diagnosed with CRC (colorectal cancer), and about 52,550 of these individuals were projected to die from the condition. Within this group, 19,550 diagnoses and 3,750 deaths are expected to occur among individuals under the age of 50. Thus, the increasing prevalence of colorectal cancer is a significant factor propelling the growth of the colorectal cancer molecular diagnostics market.
How Is The Colorectal Cancer Molecular Diagnostics Market Categorized Across Its Segment Groups?
The colorectal cancer molecular diagnostics market covered in this report is segmented –
1) By Type: Instruments, Reagents And Kits, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings
Subsegments:
1) By Instruments: PCR Machines, Sequencers, Microarrays
2) By Reagents And Kits: DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs
3) By Services: Diagnostic Testing Services, Genetic Testing Services, Consultation Services
What Market Trends Are Affecting The Colorectal Cancer Molecular Diagnostics Market?
Major companies in the colorectal cancer molecular diagnostics market are concentrating on developing innovative solutions, such as blood-based liquid biopsy screening tests. This effort aims to address the increasing demand for non-invasive, early detection tools, improve patient compliance compared to colonoscopy, and enable broader population screening as guidelines and reimbursement strategies evolve. A liquid biopsy functions as a blood test that identifies tumour-derived biomarkers from a simple blood draw; its core characteristics include minimal invasiveness, the capacity to screen asymptomatic populations, and molecular-level sensitivity. For instance, in July 2024, Guardant Health, a United States-based precision oncology company, launched Shield, a blood-based colorectal cancer screening test that received approval from the U.S. Food and Drug Administration as a primary screening option for average-risk adults aged 45 and older. Shield, a multi-marker blood assay, analyzes circulating tumour signals to identify individuals likely to have colorectal cancer; it was developed and validated within the extensive ECLIPSE clinical programme, demonstrating high sensitivity and specificity suitable for FDA primary-screening designation. The test’s composition and operation combine sequencing with proprietary bioinformatic classifiers to detect methylation and other tumour-derived signals in plasma. Its distinct advantages encompass convenience through a single blood draw, the potential to increase screening uptake, and a pathway to Medicare coverage, with applications spanning population screening and guiding positive cases to diagnostic colonoscopy, thereby offering earlier detection with fewer invasive procedures.
Which Firms Are Influencing Competition In The Colorectal Cancer Molecular Diagnostics Market?
Major companies operating in the colorectal cancer molecular diagnostics market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
Get The Full Colorectal Cancer Molecular Diagnostics Market Report:
Which Region Holds The Highest Market Share In The Colorectal Cancer Molecular Diagnostics Market?
North America was the largest region in the colorectal cancer molecular diagnostics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Colorectal Cancer Molecular Diagnostics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Colorectal Cancer Molecular Diagnostics Market 2026, By The Business Research Company
Pancreatic Cancer Diagnostic Market Report 2026
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Colorectal Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
